Influence of autolysis through fat series pharmaceuticals.

被引：3
|
作者：
Chiari, R
机构：
来源：
ARCHIV FUR EXPERIMENTELLE PATHOLOGIE UND PHARMAKOLOGIE | 1909年 / 60卷 / 4/5期
关键词：
D O I：
10.1007/BF01909654
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：256 / 264
页数：9
相关论文
共 50 条
  • [21] Express approach to the synthesis of tritium labeled pharmaceuticals.
    Shevchenko, VP
    Nagaev, IY
    Zolotarev, YA
    Sidorov, GV
    Myasoedov, NF
    SYNTHESIS AND APPLICATIONS OF ISOTOPICALLY LABELLED COMPOUNDS 1997, 1998, : 219 - 222
  • [22] Cyclodextrins - Enabling excipients: Their present and future use in pharmaceuticals.
    Thompson, DO
    Siebert, JM
    Krol, T
    Hecker, D
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U239 - U239
  • [23] Quality of sleep for osteoarthritis patients using pharmaceuticals.
    Carlson, AM
    Morris, LS
    Perfetto, EM
    Sanda, M
    Vavra, JJ
    Lunch, JM
    ARTHRITIS AND RHEUMATISM, 1996, 39 (09): : 1407 - 1407
  • [24] Biolocalization and in vivo coordination chemistry of vanadium pharmaceuticals.
    Orvig, C
    Thompson, KH
    Liboiron, BD
    McNeill, JH
    Yuen, VG
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U769 - U769
  • [25] Multicomponent Crystals in the Development of New Solid Forms of Pharmaceuticals.
    Jones, William
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2009, 65 : S102 - S102
  • [26] Radioiodination of vinyl and arylboronates: Synthesis of novel radio pharmaceuticals.
    Kabalka, GW
    Akula, MR
    Zhang, JH
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 222 : U33 - U33
  • [27] Pricing and reimbursement of pharmaceuticals. A new culture for the community pharmacist
    Moen, E
    Toverud, EL
    Grund, J
    Brinchmann, S
    PHARMACY WORLD & SCIENCE, 1998, 20 (03): : 107 - 112
  • [28] Second-generation PEG-protein pharmaceuticals.
    Roberts, MJ
    Bentley, MD
    Harris, JM
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 220 : U293 - U293
  • [29] Practical aspects of setting occupational exposure limits for pharmaceuticals.
    Ku, RH
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U275 - U275
  • [30] The significance of complex formations and solubility changes for the action of pharmaceuticals.
    Bussemaker, J
    NAUNYN-SCHMIEDEBERGS ARCHIV FUR EXPERIMENTELLE PATHOLOGIE UND PHARMAKOLOGIE, 1936, 181 : 503 - 511
12345